Emergence of MRSA in positive blood cultures from patients with febrile neutropenia - A cause for concern

Supportive Care in Cancer

Volumn 16, Issue 9, 2008, Pages 1085-1088

  Morris, Patrick G ^a   Hassan, Tidi ^a   McNamara, Mairead ^a   Hassan, Astrid ^a   Wiig, Rebecca ^a   Grogan, Liam ^a   Breathnach, Oscar S ^a   Smyth, Edmond ^a   Humphreys, Hilary ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Blood cultures; Febrile neutropenia; MRSA; VRE

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CANCER CHEMOTHERAPY; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; IRELAND; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTINEOPLASTIC AGENTS; CEREBROSPINAL FLUID; FEVER; HEMATOLOGIC TESTS; HUMANS; INCIDENCE; IRELAND; METHICILLIN RESISTANCE; NEOPLASMS; NEUTROPENIA; ONCOLOGY SERVICE, HOSPITAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 49349109517     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0398-5     Document Type: Article

References (22)

1. NV Sipsas GP Bodey DP Kontoyiannis 2005 Perspectives for the management of febrile neutropenic patients with cancer in the 21st century Cancer 103 1103 1113
2. KV Rolston 2005 Challenges in the treatment of infections caused by Gram-positive and Gram-negative bacteria in patients with cancer and neutropenia Clin Infect Dis 40 S246-S252
3. J Klastersky M Aoun 2004 Opportunistic infections in patients with cancer Ann Oncol 15 329 335
4. PF Smith MC Birmingham GA Noskin 2003 Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia Ann Oncol 14 795 801
5. LS Elting EB Rubenstein K Rolston 2000 Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care J Clin Oncol 18 3699 3706
6. E Gonzalez-Barca A Fernandez-Sevilla J Carratala 1996 Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution Eur J Clin Microbiol Infect Dis 15 291 296
7. AT Tomiak JC Yau SD Huan 1994 Duration of intravenous antibiotics for patients with neutropenic fever Ann Oncol 5 441 445
8. P Mathur R Chaudhry L Kumar 2002 A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes Med Oncol 19 267 272
9. PA Pizzo 1993 Management of fever in patients with cancer and treatment-induced neutropenia N Engl J Med 328 1323 1332
10. P McDonald E Mitchell H Johnson 2003 Epidemiology of MRSA: the North/South study of MRSA in Ireland 1999 J Hosp Infect 54 130 134
11. FM MacKenzie J Bruce MJ Struelens 2007 ARPAC Steering Group. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals Clin Microbiol Infect 13 269 276
12. R Reynolds N Potz M Colman 2004 BSAC extended working party on bacteraemia resistance surveillance. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme J Antimicrob Chemother 53 1018 1032
13. Irish European Antimicrobial Resistance Surveillance System Steering Group (EARSS) EARSS Report for Quarter 1 2007 (Ireland). Health Services Executive, Health Protection Surveillance Centre, Dublin, http://www.ndsc.ie/ hpsc/A-Z/MicrobiologyAntimicrobialResistance/ EuropeanAntimicrobialResistanceSurveillanceSystemEARSS/EARSSSurveillanceReports/ 2007Reports/
14. TJ Smith J Khatcheressian GH Lyman 2006 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 3187 3205
15. MS Aapro DA Cameron R Pettengell 2006 EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours Eur J Cancer 42 2433 2453
16. National Cancer Institute (2003) Common terminology criteria for adverse events v3.0 (CTCAE). National Cancer Institute, Bethesda, www.cancer.gov
17. PA Pizzo S Ladisch RM Simon 1978 Increasing incidence of Gram-positive sepsis in cancer patients Med Pediatr Oncol 5 241 244
18. Paul M, Borok S, Fraser A et al (2005) Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Cochrane Database Syst Rev (3) Art. No.: CD003914. DOI 10.1002/14651858.CD003914.pub2
19. AK Gopal VG Fowler Jr M Shah 2000 Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy J Clin Oncol 18 1110 1115
20. M Figuera Esparza M Carballo M Silva 2006 Microbiological isolates in patients with febrile neutropenia and hematological neoplasias Rev Esp Quimioter 19 247 251
21. M Paul D Yahav A Fraser L Leibovici 2006 Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials J Antimicrob Chemother 57 176 189
22. M Paul S Borok A Fraser 2005 Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials J Antimicrob Chemother 55 436 444